News
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Semperit AG Holding: Operating result in Q1 expected to be higher than the previous year; full-year earnings forecast remains unchanged
Semperit AG Holding expects higher Q1 operating result compared to last year, maintains full-year earnings forecast. EBITDA for Q1 2026 estimated at EUR 26 million -
-
-
-
-
PRESS RELEASE
Form 8.3 - The Vanguard Group, Inc.: A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
The Vanguard Group, Inc. discloses a 5.32% stake in LondonMetric Property plc and a 0.93% stake in Schroder Real Estate Investment Trust Limited as of 16 April 2026 -
PRESS RELEASE
Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc to USD 7.50 target price due to recent corporate updates and pipeline progress, including MAVERIC trial advancements